Rehovot, Israel

Yael Golani

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Beeologics, Inc.. Active years: 2020.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Viral Control: The Work of Yael Golani

Introduction

Yael Golani is an innovative inventor based in Rehovot, Israel. He has made significant contributions to the field of viral control, particularly in the context of mites and bees. His work focuses on utilizing RNA interference technology to combat viral infections, which is crucial for maintaining healthy bee populations.

Latest Patents

Yael Golani holds a patent for "Compositions and methods for virus control in mites and bees." This patent discloses compositions and methods for providing viral control in mites and bees by using RNA interference technology. The invention specifically targets viral sequences to prevent and treat viral infections in these important pollinators.

Career Highlights

Golani is associated with Beeologics, Inc., a company dedicated to advancing the health of bees through innovative solutions. His work at Beeologics has positioned him as a key player in the field of agricultural biotechnology, particularly in the area of pest and disease management.

Collaborations

Yael collaborates with Merav Gleit-Kielmanowicz, who is also involved in research related to bee health and viral control. Their partnership exemplifies the importance of teamwork in scientific research and innovation.

Conclusion

Yael Golani's contributions to viral control in bees and mites highlight the critical intersection of technology and agriculture. His innovative approaches are essential for the sustainability of bee populations, which play a vital role in our ecosystem.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…